Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

0.7047

+0.0337 (5.02%)

At close: Mar 26, 2026, 4:00 PM EDT

0.7000

-0.0047 (-0.67%)

After-hours: Mar 26, 2026, 4:10 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biotechnology (Startups)	1.50M	583.23K
Biotechnology (Startups) Growth	157.63%	-
Total	1.50M	583.23K
Total Growth	157.63%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Source: S&P Global Market Intelligence.